# Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases

> **NCT04410133** · PHASE3 · COMPLETED · sponsor: **Blue Earth Diagnostics** · enrollment: 151 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **DRUG:** 18F fluciclovine

## Key facts

- **NCT ID:** NCT04410133
- **Lead sponsor:** Blue Earth Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-26
- **Primary completion:** 2023-06-05
- **Final completion:** 2023-06-05
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410133, "Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04410133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*